Orencia (Abatacept) 125mg/mL Clickjet Injection

$5,600.00

Drug Info: ApoThera Drug Disease Clinical Support App

Psoriatic Arthritis
SC Dose
– 125 mg SC once weekly
– Administer without an IV loading dose
– If transitioning from IV therapy to SC therapy, administer the first SC dose instead of the next scheduled IV dose.
Rheumatoid Arthritis (RA)
SC Dose
– 125 mg SC once weekly
– SC dosing may be initiated with or without an IV loading dose.
– If initiating with an IV loading dose, administer the initial IV infusion (using the weight-based dosing), then administer 125 mg subcutaneously within 24 hours of the infusion, followed by 125 mg subcutaneously once weekly thereafter.
– If transitioning from IV therapy to SC therapy, administer the first SC dose instead of the next scheduled IV dose.
– Discontinue in patients who develop a serious infection
Juvenile Idiopathic Arthritis (JIA)
– IV Dosage according to Body Weight.
– Repeat dose at 2 weeks and 4 weeks after initial dose and every 4 weeks thereafter.
Children ≥6 years and <75 kg (IV Dose)
– 10 mg/kg
Children ≥6 years and ≥75 kg (IV Dose)
75 to 100 kg:  750 mg
>100 kg: 1,000 mg (maximum dose)
Children ≥2 years (SC Dose)
– Administer without an IV loading dose and use weight-based dosing
10 to <25 kg: 50 mg SC once weekly
≥25 to <50 kg: 87.5 mg SC once weekly
≥50 kg: 125 mg SC once weekly
Find a Physician:
NDC: 00003-2188-51 Category:

4 Syringes = 1 Unit

Description

SC Administration
– Allow prefilled syringe and autoinjector to warm to room temperature (for 30 to 60 minutes and 30 minutes, respectively) prior to administration.
– Inject into the front of the thigh (preferred), abdomen (except for 2-inch area around the navel), or the outer area of the upper arms (if administered by a caregiver).
– Rotate injection sites (≥1 inch apart); do not administer into tender, bruised, red, or hard skin.
 
Storage
– Store at 2°C to 8°C (36°F to 46°F)
– Do not freeze
– Protect from light
 
Monitoring
– Signs and symptoms of infection
– Signs and symptoms of hypersensitivity reaction
– Hepatitis and TB screening prior to therapy initiation